AlloMEK Therapeutics

Business Data, Corporate Office and Headquarter Address

About

AlloMEK Therapeutics is Biotechnology in United States that focus on developer business. Founded in 2011. They cover business area such as developer, target therapeutic, rare and debilitate disease, MEK kinase inhibitor, previous MEK inhibitor, combination, physician, clinical response.

Business Type

Biotechnology

Country

United States

Founded

2011
( 13 years old in 2024 )

Company Focus

Developer

Website

-

Corporate Office and Headquarter Office address:

4 Research Drive
Woodbridge, CT 06525
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developertarget therapeuticrare and debilitate diseaseMEK kinase inhibitorprevious MEK inhibitorcombinationphysicianclinical response

* We use standard office opening hours in near AlloMEK Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

AlloMEK Therapeutics Frequently Asked Questions

What or who is AlloMEK Therapeutics?

AlloMEK Therapeutics is Biotechnology business from United States that founded in 2011 (13 years old in 2024), AlloMEK Therapeutics business is focusing on Developer.

Where is AlloMEK Therapeutics headquarter and corporate office address?

AlloMEK Therapeutics headquarter office and corporate office address is located in 4 Research Drive Woodbridge, CT 06525 United States.

Where is AlloMEK Therapeutics country origins?

AlloMEK Therapeutics was founded in United States.

What is Developer business focus on?

In 2024, AlloMEK Therapeutics is currently focus on developer sector.

Developer Business Interest from Google Trend

Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with AlloMEK Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.